How investors can benefit from the fight against obesity

Production at Novo Nordisk

The pharmaceutical company sells a product that has been shown in large studies to reduce weight by more than 15 percent.

(Photo: Novo Nordisk)

Cologne It’s a stark contrast: on the one hand, hundreds of millions of people around the world suffer from hunger. And on the other hand, more and more people are affected by obesity.

According to a report by the World Health Organization (WHO), in 2020 764 million people worldwide suffered from obesity, as the medical term is called. According to the WHO forecast, by 2030 the number will rise to over a billion. The experts see obesity as a disease of epidemic proportions.

As difficult as the medical side is: From an investor’s point of view, obesity is a “pronounced growth market”, writes Maximilian-Benedikt Köhn, analyst and fund manager at DJE Kapital, in an industry commentary. In the following, the Handelsblatt shows which individual stocks investors can rely on this market and how analysts assess the prospects.

Read on now

Get access to this and every other article in the

Web and in our app free of charge for 4 weeks.

Continue

Read on now

Get access to this and every other article in the

Web and in our app free of charge for 4 weeks.

Continue

source site-11